Epidemiological, immunological and genetic mapping of adverse reactions to COVID-19 vaccine | Pandemic PACT Tracker

Key facts

Disease
COVID-19
Start & end year
N/A
Known Financial Commitments (USD)
$1,803,000
Principal Investigator
Mia Wadelius
Research Location
Sweden
Lead Research Institution
N/A
Research Priority Alignment
N/A

Research Category
Epidemiological studies
Research Subcategory
Disease surveillance & mapping
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified

Abstract

15 Publications linked via Europe PMC

Last Updated:6 days ago

View all publications at Europe PMC

SARS-CoV-2 infection and COVID-19 vaccination and the risk for new-onset type 1 diabetes: a register-based population study in Sweden.

Risk of venous thromboembolism after SARS-CoV-2 vaccination-Evidence from genome-wide association study and population-based observational study.

Impact of interstitial lung disease on COVID-19 severity: A nationwide register study.

Evaluating IL1RA-Autoantibodies Across SARS-CoV-2-Related Diseases.

Effect of COVID-19 vaccination appointment letters on uptake by sociodemographic characteristics: a regression discontinuity analysis in Sweden, December 2020 to September 2021.

Area-related sociodemographic factors and the risk of severe COVID-19: a longitudinal study of the total adult population in Sweden.

Genome-wide association study of myocarditis and pericarditis following COVID-19 vaccination.

Regional differences in COVID-19 vaccine uptake and their determinants among Swedish older adults.

Clarification on methodology used in the study investigating COVID-19 vaccination and cardiovascular events.